Evrys Bio
The Luftig laboratory uses cutting-edge approaches to characterize Epstein-Barr virus (EBV) infection, aiming to discover fundamental molecular circuits underlying transcriptional control, viral manipulation of host signaling pathways, and metabolic regulation that collectively influence infected cell fate decisions. This virus is acquired early in life and latently infects virtually all adults worldwide. In the immune suppressed, EBV promotes lymphomas in the B cells that it naturally infects. It can also infect epithelial cells and other lymphocytes contributing to human cancers as wide-ranging as nasopharyngeal and gastric carcinoma to aggressive NK/T-cell, Burkitt, and Hodgkin lymphomas.
This person is not in the org chart
This person is not in any offices
Evrys Bio
Evrys Bio’s approach to antiviral therapy is different. Uniquely, Evrys Bio antivirals target special human proteins, known as sirtuins, enhancing their natural ability to fight powerful infections.